Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis. - Wikidata - wikimedia - TriplyDB

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

http://www.wikidata.org/entity/Q37854494

about

Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem"Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.Cardiomyocyte culture - an update on the in vitro cardiovascular model and future challenges.Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms

P2860

Q26746924-75959042-ADE4-4B94-A989-9D4543F0BD8E Q34996149-5C33F58B-F73F-4F3F-8875-2A17AB398D0E Q35246995-AEE1F42C-F660-4670-8C70-5FA4CA2B1A97 Q38167330-A71721DE-8A80-4E6A-9998-CA31B7BFBC2E Q38255906-A583EE4C-DDB8-4D38-93EE-62D61199B702 Q40197234-7027F5E3-F81D-42E8-B0DB-C9580D6EB6C3 Q54959206-30C8A142-3030-4A06-B6BE-547B19906A84 Q58554222-7C95D2D5-B961-42B3-8486-3FA3FA15EA69

P2860

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

http://www.wikidata.org/entity/Q37854494

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@en

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@nl

type

label

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@en

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@nl

prefLabel

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@en

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@nl

P1433

Q37854494-B3CB697E-1FA2-4259-AB29-66DDC102A4E5

P1476

Q37854494-8D5CBD46-B9C4-43A0-B0C6-1F331F3DC485

P2093

Q37854494-094DBCF7-153A-4183-8DFA-DDD6DBC53C96

Q37854494-34D0541A-A887-45FF-BB2C-ED06EAC6F9E8

Q37854494-382C4176-C1A2-4DE4-A70B-1821D4EA8DFC

Q37854494-56D1072E-CD12-4D8F-BD6B-B33D1D3CA2D8

Q37854494-81CB0DF3-4419-4DA4-BBB7-1D7908224098

Q37854494-B1BBFE8D-ADFA-4690-9639-BE50C66EF7C4

Q37854494-BCD169F9-9784-4283-BAB6-2DE44507F98C

Q37854494-BEC8ED7C-07B7-4BC9-AD26-2B2D28A1F45D

Q37854494-EF6042A2-65DE-449F-B676-6E46B47E766F

Q37854494-FFBD46CA-0704-411E-A471-57FDE64A51F3

P2860

Q37854494-039968C5-BCC3-49BC-B4C0-E7F603938B2C

Q37854494-0A55F979-A432-40F7-AA9D-A54B4090850C

Q37854494-16DA2AF6-2DAD-4D6C-884B-69BA1DE8766D

Q37854494-2141E59E-4225-4E53-B149-AD433CCC4719

Q37854494-264A8C3E-406F-4F7C-82D8-B5A43F10CA44

Q37854494-3DAB6C66-A761-4C38-BE67-499550D41AFB

Q37854494-4B52099D-790B-4EB7-9316-3213C6C8753E

Q37854494-537DC4B7-5E69-42E5-A0A9-EEEE123A00E2

Q37854494-56797008-A926-4EB1-9926-9F99268E8EE7

Q37854494-6401B735-5AFF-4BB6-9032-2355FF03FD64

P2888

Q37854494-70ACBB83-4E93-4320-9BDE-92363448A4C6

P304

Q37854494-EBD257D9-7486-4484-BC9F-3A58118A67FF

P31

Q37854494-8A962D20-A701-485D-82EB-8B8B42532CC6

P356

Q37854494-A5ABB01A-4EFD-4AF2-8853-C0F32CF4C86C

P433

Q37854494-F73D41A4-2999-4E34-BA68-8BF5EE6EA8A9

P478

Q37854494-0FAD3943-0F41-4DA3-9A19-BD5F4C11E9E6

P577

Q37854494-A8F778D0-AF80-4206-B573-B70F1FCCE40B

P5875

Q37854494-A16C13EE-D06C-44C6-B34E-5E0773BC7DE6

P698

Q37854494-18AACBC7-7F7B-44B9-852E-A588345E6277

P356

S00280-011-1614-Z

P1433

Cancer Chemotherapy and Pharmacology

P1476

Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.

@en

P2093

Antonio Nieto

http://www.w3.org/2001/XMLSchema#string

Arturo Soto-Matos

http://www.w3.org/2001/XMLSchema#string

Carmen Kahatt

http://www.w3.org/2001/XMLSchema#string

Claudia Lebedinsky

http://www.w3.org/2001/XMLSchema#string

Elena Roy

http://www.w3.org/2001/XMLSchema#string

Javier Gómez

http://www.w3.org/2001/XMLSchema#string

Pilar Lardelli

http://www.w3.org/2001/XMLSchema#string

Trilok Parekh

http://www.w3.org/2001/XMLSchema#string

Vicente Alfaro

http://www.w3.org/2001/XMLSchema#string

Youn C Park

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac dysfunction in the trastuzumab clinical trials experience

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.

The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?

Preclinical and clinical results with the natural marine product ET-743.

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

P2888

s00280-011-1614-z

P304

1223-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-011-1614-Z

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50420895

http://www.w3.org/2001/XMLSchema#string

P698

21416137

http://www.w3.org/2001/XMLSchema#string